Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

TPEX:4747 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	261.73	1,050	1,070	1,088	168.47	202.23
Trading Asset Securities	-	102.3	-	-	-	-
Cash & Short-Term Investments	261.73	1,152	1,070	1,088	168.47	202.23
Cash Growth	-76.03%	7.64%	-1.61%	545.58%	-16.70%	-31.60%
Accounts Receivable	124.46	114.56	119.17	124.74	115.37	91.64
Other Receivables	1.6	1.02	1.14	1.68	0.92	0.97
Receivables	126.06	115.59	120.31	126.42	116.29	92.61
Inventory	212.6	188.47	140.9	138.81	127.03	146.48
Prepaid Expenses	2.17	0.65	3.11	4.68	2.18	4.56
Other Current Assets	0.33	0.85	2.45	1.26	0.57	0.62
Total Current Assets	602.89	1,457	1,337	1,359	414.53	446.49
Property, Plant & Equipment	616.94	606.75	599.23	605.59	592.17	382.72
Long-Term Investments	1,317	15.75	14.01	15.77	15.38	15.41
Other Intangible Assets	-	-	1.41	2.83	4.24	5.66
Long-Term Deferred Tax Assets	2.47	3.13	2.64	2.96	2.96	3.14
Other Long-Term Assets	19.19	10.83	11.15	7.03	9.94	173.72
Total Assets	2,559	2,094	1,965	1,993	1,039	1,027

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	59.97	58.61	39.96	67.82	33.32	34.99
Short-Term Debt	645	200	60	60	60	80
Current Portion of Long-Term Debt	-	60.96	-	-	-	-
Current Income Taxes Payable	4.42	0.17	11.37	21.43	16.47	13.24
Current Unearned Revenue	11.12	6.15	7.86	7.35	7.06	8.39
Other Current Liabilities	99.76	58.32	51.95	63.41	50.72	42.3
Total Current Liabilities	820.26	384.21	171.14	220.01	167.56	178.91
Long-Term Debt	-	-	90.22	100.83	-	-
Other Long-Term Liabilities	-	0.16	-	0.15	-	-
Total Liabilities	820.26	384.37	261.36	320.99	167.56	178.91

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	454.61	453.81	449.32	436.68	300.19	300.19
Additional Paid-In Capital	1,074	1,074	1,049	1,038	400.86	400.86
Retained Earnings	219.38	190.37	217.49	196.32	180.85	157.4
Comprehensive Income & Other	-9.92	-9.06	-11.61	0.68	-10.24	-10.21
Shareholders' Equity	1,738	1,709	1,704	1,672	871.66	848.24
Total Liabilities & Equity	2,559	2,094	1,965	1,993	1,039	1,027

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	645	260.96	150.22	160.83	60	80
Net Cash (Debt)	-383.27	890.87	919.84	926.78	108.47	122.23
Net Cash Growth	-	-3.15%	-0.75%	754.40%	-11.26%	-26.22%
Net Cash Per Share	-4.12	9.57	9.88	12.20	1.80	2.03
Filing Date Shares Outstanding	90.92	90.76	89.86	87.34	60.04	60.04
Total Common Shares Outstanding	90.92	90.76	89.86	87.34	60.04	60.04
Working Capital	-217.38	1,073	1,166	1,139	246.96	267.58
Book Value Per Share	19.12	18.83	18.96	19.14	14.52	14.13
Tangible Book Value	1,738	1,709	1,702	1,669	867.41	842.58
Tangible Book Value Per Share	19.12	18.83	18.95	19.11	14.45	14.03
Land	431.69	431.69	431.69	431.69	431.69	265.1
Buildings	98.58	95.63	94.98	93.64	90.23	89.32
Machinery	301.8	283.98	282.6	262.63	251.35	186.43
Construction In Progress	20.63	21.24	7.02	19.82	4.45	16.66

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error